Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05500391

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

Randomized Phase II Trial Evaluating Compliance With Monitoring Conducted Either by a Hospital-based Physician in Person or by a Nurse in Remote Monitoring

Status
Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
88 (estimated)
Sponsor
Centre Oscar Lambret · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a multicenter, interventional, randomized study among adult patients recently diagnosed with a rare tumor (\<12 months). The study will aim to compare compliance with the personalized post-treatment surveillance plan, established for each patient according to national guidelines, when the surveillance is conducted in person by a hospital-based physician (control arm) or remotely by a trained nurse (experimental arm).

Detailed description

The primary objective of this study is to compare 2-year compliance with the personalized post-treatment surveillance plan between the two arms. The secondary objectives are to compare between the two arms : * Long-term compliance (5-year follow-up) * Use of care * Oncological events and their management * Supportive care needs The exploratory objectives are to : * Evaluate the costs in terms of medical transportation * Evaluate and compare patients' satisfaction and psychological well-being (in terms of anxiety/depression) * Evaluate the homogeneity of the impact of the intervention according to covariates (gender, tumor pathology, occupational status, and center) * Evaluate the reasons for recruitment failures

Conditions

Interventions

TypeNameDescription
OTHEROncological Follow-upPost-cancer surveillance (including biological, clinical and imaging exams depending on the condition)

Timeline

Start date
2024-02-28
Primary completion
2026-10-01
Completion
2032-07-01
First posted
2022-08-15
Last updated
2026-03-18

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05500391. Inclusion in this directory is not an endorsement.